Alembic Pharmaceuticals (APLLTD) Share Price Near 52-Week High as Stock Traded at Rs 1,055.55
- November 18, 2026
- Posted by: Chaitanya Auti
- Category: News
Alembic Pharmaceuticals Share Price is trading at Rs 1,055.55, up 0.48% today, and remains close to its 52-week high while the company carries a market capitalisation of Rs 20,753.13 Cr. According to latest Univest data, Alembic Pharmaceuticals Share Price is being watched because the current price is within the near-high zone, even though the data does not establish a company-specific trigger. The move matters for Alembic Pharmaceuticals Share Price Today because the stock is already well above its 50-day and 200-day averages, while the wider setup also keeps valuation, sector positioning and peer comparison in view. Univest data places the event in the context of Indian Stock Market search interest around Stocks in News and 52 Week High Stocks.
As of 18 November 2026 at 9:22 AM IST, Alembic Pharmaceuticals Share Price stood at Rs 1,055.55 after opening at Rs 1,048 and moving between Rs 1,048 and Rs 1,058.80. The stock was Rs 5 above the previous close of Rs 1,050.55. For readers tracking Alembic Pharmaceuticals Share Price Today, the latest Univest figures confirm a near 52-week high event, not a new yearly high. In Alembic Pharmaceuticals Stock News, that makes the price action relevant on its own, without assigning a catalyst that the numbers do not show. Univest continues to track Alembic Pharmaceuticals Share Price Live and Alembic Pharmaceuticals Share Price Update as the market works through this range.
Alembic Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,055.55 |
| Previous Close | Rs 1,050.55 |
| Today's Move | +Rs 5 (+0.48%) |
| Open | Rs 1,048 |
| High | Rs 1,058.8 |
| Low | Rs 1,048 |
| Market Capitalisation | Rs 20,753.13 crore |
Alembic Pharmaceuticals Ltd. (APLLTD) traded at Rs 1,055.55 versus the previous close of Rs 1,050.55, a rise of 0.48%. The stock opened at Rs 1,048, reached a high of Rs 1,058.8 and touched a low of Rs 1,048.
Alembic Pharmaceuticals Share Price Today shows a narrow intraday band around the upper end of the range, with the stock last traded at Rs 1,055.55 after a Rs 5 rise from the previous close. The day opened at Rs 1,048, matched the day low at Rs 1,048 and touched Rs 1,058.80 at the high, leaving the current price just below that top. For Alembic Pharmaceuticals Share Price, this means the stock is trading near the one-year high zone rather than below it, and the latest Univest read confirms that it is within 2% of the 52-week peak. In Alembic Pharmaceuticals Share News, that proximity is the main fact to note. The event is best read as price action near a yearly high, not as a statement about why the move happened. For Alembic Pharmaceuticals Share Price Today, the key point is the distance to the upper band and the firm hold above the prior session’s level.
What exactly happened today is simple: Alembic Pharmaceuticals Share Price moved up by 0.48% and stayed in a tight range near the top of its daily spread. Univest data also shows that Alembic Pharmaceuticals Share Price sits far above its 50-day average of Rs 863.57 and 200-day average of Rs 821.97, which helps frame the longer-run price backdrop without making any unsupported behavioural claim. For investors searching Alembic Pharmaceuticals Stock News or Alembic Pharmaceuticals Share Price News, the event is defined by price proximity to the 52-week high and the absence of any separate company-specific explanation in the latest figures. Alembic Pharmaceuticals Share Price Today therefore remains the central market note, while Univest keeps the focus on the verified numbers rather than a narrative that is not established by the data.
Alembic Pharmaceuticals Ltd. (APLLTD) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,753.13 crore |
| P/E Ratio | 24.47x |
| P/B Ratio | 3.47x |
| ROE | 12.35% |
| ROCE | 11.74% |
| EPS | Rs 42.93 |
| Book Value Per Share | Rs 302.42 |
| Dividend Yield | 1.14% |
Alembic Pharmaceuticals Ltd. (APLLTD) fundamental metrics show P/E 24.47x, P/B 3.47x, ROE 12.35%, ROCE 11.74%. These figures provide context only and are not a buy or sell signal.
Alembic Pharmaceuticals Ltd. has a market capitalisation of Rs 20,753.13 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.47x, P/B at 3.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.35% and ROCE of 11.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 42.93, book value per share of Rs 302.42, dividend yield of 1.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.58x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 24.47x |
| Benchmark Median P/E | 26.58x |
| Benchmark Average P/E | 50.62x |
| Benchmark P/E Range | 0x to 1,425.63x |
| Company P/B Ratio | 3.47x |
| Benchmark Median P/B | 2.73x |
| Company ROE | 12.35% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 11.74% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 20,753.13 crore |
| Benchmark Median Market Cap | Rs 747.19 crore |
Alembic Pharmaceuticals Ltd. (APLLTD) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Alembic Pharmaceuticals Ltd. (APLLTD) has a P/E ratio of 24.47x, which is below the benchmark median of 26.58x, a difference of -7.94%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alembic Pharmaceuticals Ltd. (APLLTD) has a ROE of 12.35%, which is above the benchmark median of 11.22%, a difference of +10.07%. Alembic Pharmaceuticals Ltd. (APLLTD) has a ROCE of 11.74%, which is below the benchmark median of 13.1%, a difference of -10.38%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Granules India Ltd. | GRANULES | 21,812.84 | 31.21 | 3.39 | 14.13 | 15.74 |
| ONESOURCE SPECL PHARMA L | ONESOURCE | 18,472.86 | 0 | 3.06 | -1.26 | 0.44 |
| Eris Lifesciences Ltd. | ERIS | 18,418.93 | 26.68 | 4.55 | 19.23 | 14.47 |
| Shilpa Medicare Ltd. | SHILPAMED | 18,357.31 | 53.95 | 6.5 | 9.82 | 11.43 |
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 17,820.56 | 24.83 | 4.38 | 20.79 | 24.97 |
Alembic Pharmaceuticals Ltd. (APLLTD) has a P/E ratio of 24.47x compared with the displayed peer median of 26.68x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.35% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 11.74% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Alembic Pharmaceuticals Ltd. (APLLTD) has a market capitalisation of Rs 20,753.13 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Alembic Pharmaceuticals
- Alembic Pharmaceuticals Share Price is trading at Rs 1,055.55, just below the day high of Rs 1,058.80.
- Alembic Pharmaceuticals Share Price Today remains near its 52-week high and one-year high zone.
- Alembic Pharmaceuticals Share Price carries a market capitalisation of Rs 20,753.13 Cr.
- Alembic Pharmaceuticals Share Price has a P/E ratio of 24.47 and a P/B ratio of 3.47.
- Alembic Pharmaceuticals Share Price sits above its 50-day and 200-day averages at Rs 863.57 and Rs 821.97.
About Alembic Pharmaceuticals
Alembic Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Univest identifies the company through its listed market profile, price behaviour and financial metrics, which together frame Alembic Pharmaceuticals Share Price Today. The stock is tracked on NSE and BSE as APLLTD, and its company overview is best read alongside the reported valuation and return ratios. For readers following Alembic Pharmaceuticals Stock News, the company profile is straightforward: the latest Univest figures focus on listed-market data, sector classification and the current price relationship to the 52-week high. That is the practical context for Alembic Pharmaceuticals Share Price and related Alembic Pharmaceuticals Share News coverage.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What is Alembic Pharmaceuticals Share Price today?
Ans. Alembic Pharmaceuticals Share Price is Rs 1,055.55 as of 18 November 2026 at 9:22 AM IST. It is up 0.48% from the previous close of Rs 1,050.55 and remains near its 52-week high.
Why is Alembic Pharmaceuticals Share Price in focus?
Ans. Alembic Pharmaceuticals Share Price is in focus because it is trading close to its 52-week high. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst.
What does Alembic Pharmaceuticals Share Price Today show about intraday movement?
Ans. Alembic Pharmaceuticals Share Price Today shows a range between Rs 1,048 and Rs 1,058.80. The stock opened at Rs 1,048 and last traded at Rs 1,055.55, which keeps it near the upper part of the band.
How does Alembic Pharmaceuticals Share Price compare with its 52-week high?
Ans. Alembic Pharmaceuticals Share Price is close to its 52-week high zone and is within 2% of that level. The event indicates proximity to the yearly high, not a new record level.
What are the key valuation metrics for Alembic Pharmaceuticals Share Price?
Ans. Alembic Pharmaceuticals Share Price carries a P/E ratio of 24.47 and a P/B ratio of 3.47. EPS is Rs 42.93, book value is Rs 302.42 and dividend yield is 1.14%.
How does Alembic Pharmaceuticals Share Price compare with industry benchmarks?
Ans. Alembic Pharmaceuticals Share Price has a P/E below the industry median of 26.58 and a P/B above the median of 2.73. Its ROE is above the median, while ROCE is below the median.
What is the market capitalisation linked to Alembic Pharmaceuticals Share Price?
Ans. Alembic Pharmaceuticals Share Price is associated with a market capitalisation of Rs 20,753.13 Cr. In the same industry benchmark, that is above the median company size and above the average market capitalisation.
Where can readers track Alembic Pharmaceuticals Share Price on Univest?
Ans. Readers can track Alembic Pharmaceuticals Share Price on Univest for live price updates, 52-week levels, valuation ratios, return metrics and peer context. Univest also groups Alembic Pharmaceuticals Stock News and related market insights for easy follow-up.
Track Alembic Pharmaceuticals Share Price on Univest
Use Alembic Pharmaceuticals Ltd. (APLLTD) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Alembic Pharmaceuticals Share Price on Univest for live share price updates, 52-week levels, valuation ratios, return metrics, sector context and peer comparison. Univest also keeps Alembic Pharmaceuticals Share Price Today visible alongside broader market insights so readers can follow Alembic Pharmaceuticals Stock News, Alembic Pharmaceuticals Share Price Update and Alembic Pharmaceuticals Latest News in one place.